Difference between revisions of "Team:TCU Taiwan/Project/Overview"

(Blanked the page)
 
(20 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{TCU_Taiwan/CSS}}
 
<html>
 
<style type="text/css">
 
  
#form {
 
        position:static;
 
margin-left:10%;
 
margin-top:2%;
 
width:80%;
 
height:50%;
 
z-index:1;
 
        overflow:visible;
 
        margin-bottom:2%;
 
        display: inline-block
 
}
 
</style>
 
<body>
 
<img src="https://static.igem.org/mediawiki/2015/5/5f/2015tcutaiwanProject.jpg"  width="100%"  align="center" />
 
<div id="form" style="background: rgba(100%,100%,100%,0.5); overflow-x:hidden;overflow-y:hidden; ">
 
<h1>
 
<table width="97%" align="center">
 
  <tr><br>
 
    <td align="center">
 
        <span style="font-family:Arial Black;;line-height: 150%;">
 
            <font size="8"><font-weight: 900;>
 
                <br>AMP. <I>coli</I>
 
            </font>
 
        </span>
 
    </td>
 
  </tr>
 
</table>
 
 
<table width="97%" align="center">
 
<tr>
 
<td width="3%"></td>
 
    <td>
 
<p align="justify" ><span style="font-family:Calibri;line-height: 150%;"><font size="5">
 
Antimicrobial peptide (AMPs) has an extensive ability in disinfect. Unlike antibiotics, AMPs use chargeability puncture the cell membrane to kill the bacteria therefore by passing bacterial antibiotic drug resistance mechanisms. <a href="https://2015.igem.org/Team:TCU_Taiwan/Project/Overview#tcu_references_1">[1]</a> Two kinds of AMPs were selected as our reagents: Epinecidin-1 and Signiferin. </br>
 
      Epinecidin-1 is a peptide comes from <I>Epinephelus coioides</I>, and Signiferin is comes from <I>Crinia signifera</I>. Both of them are extracted from the skin mucus. In addition, epinecidin-1 has the ability to help wounds healing and has been proven by animal studies. <a href="https://2015.igem.org/Team:TCU_Taiwan/Project/Overview#tcu_references_2"> [2]</a> Moreover, signiferin have great ability in disinfect Methicillin-Resistant <I>Staphylococcus aureus</I> (S. aureus), and had already been kindly proved by the TU-Delft 2013 iGEM team. <a href="https://2015.igem.org/Team:TCU_Taiwan/Project/Overview#tcu_references_3">[3]</a>Combining these two properties, we believe that can alleviate the serious problem of skin injury.</br>
 
      To produce AMPs and control AMPs expression, we apply the Lac operon and ligate the DNA of signal peptide into E. <I>coli</I> to help AMPs secret into culture medium. <a href="https://2015.igem.org/Team:TCU_Taiwan/Project/Overview#tcu_references_4">[4][5]</a> Next, to prove that AMPs have the extensive ability in disinfection and helps the wound healing, selected cells and bacteria were tested <I>in vitro</I>, including the squamous epithelial cell and endothelial cell of the blood vessel and MRSA, and mice were used <I>in vivo</I>. Ultimately, create a wound dressing based on the above procedure.</br>
 
      An excellent dressing made of AMPs will make a fast recovery.</br>
 
<br>
 
</font>
 
</span>
 
</p>
 
</td>
 
<td width="3%"></td>
 
  </tr>
 
</table>
 
</h1>
 
</div>
 
 
 
<div id="form" style="background: rgba(100%,100%,100%,0.5); overflow-x:hidden;overflow-y:hidden; ">
 
<p align="center">
 
<img align="middle" src="https://static.igem.org/mediawiki/2015/f/f0/Tcu_Taiwan_Project_overview.jpg" width=100% height=100% >
 
</p></div>
 
 
 
    <div id="form" style="background: rgba(100%,100%,100%,0.5); overflow-x:hidden;overflow-y:hidden; ">
 
      <table width="97%" align="center">
 
<tr>
 
<td width="3%"></td>
 
    <td>
 
  <span style="font-family:Calibri;line-height: 150%;text-align:justify;"><font size="5">
 
 
 
  <p>
 
    <a href="https://2015.igem.org/Team:TCU_Taiwan/Project/Our_Design">
 
            &nbsp;&nbsp;Antimicrobial peptide
 
    </a>
 
  </p>
 
 
 
<p align="justify">&bull;&nbsp;Epinecidin-1:</p>
 
 
<p align="justify">1. From the skin mucus of <I>Epinephelus coioides</I> a kind of fish.
 
</p> 
 
<p align="justify">
 
2. Has function of killing bacteria.
 
</p>
 
<p align="justify">
 
3. In addition, it has the ability to help wounds healing and has been proven by animal studies.
 
</p>
 
  <br>
 
<p align="justify">&bull;&nbsp; Signiferin:
 
</p> 
 
<p align="justify">
 
1. From the skin mucus of <I>Crinia signifera</I> a kind of tree frog.
 
</p>
 
<p align="justify">
 
2. Have function of killing bacteria.
 
</p>
 
<p align="justify">
 
3. Have great ability in disinfect Methicillin-Resistant <I>Staphylococcus aureus</I> (MRSA).
 
</p>
 
<p align="justify">
 
4. Had already been kindly proved by the 2013 TU-Delft iGEM team.
 
</p>
 
  <br>
 
 
<p>
 
<a href="https://2015.igem.org/Team:TCU_Taiwan/Project/Experimental">Signal peptide: </a>
 
  </p>
 
<p align="justify">
 
1. Helps AMPs to secret out of E. coli.
 
</p>
 
<p align="justify">
 
2. From <I>Streptomyces lividans</I> to trasport chitinase C to secretion system, which has been proven to work in E.<I>coli</I>
 
</p>
 
<p align="justify">
 
by reference.
 
  </p>
 
  <br>
 
 
  <p style="font-size:0.7cm" align="justify">
 
<a href="https://2015.igem.org/Team:TCU_Taiwan/Project/Reference">Wound dressing:</a>
 
  </p>
 
 
  <p align="justify">
 
Based on AMPs to develop into a potential material of wound dressing. 
 
  </p>
 
 
 
</font>
 
</span>
 
</td>
 
<td width="3%"></td>
 
  </tr>
 
</table>
 
</div>
 
<a name="tcu_references_1"></a>
 
<div id="form" style="background: rgba(100%,100%,100%,0.5); overflow-x:hidden;overflow-y:hidden; ">
 
<table width="97%" align="center">
 
<tr>
 
<td width="3%"></td>
 
    <td>
 
<span style="font-family:Calibri;line-height: 150%;text-align:justify;"><font size="5">
 
    <p style="font-size:1.2cm" align="center">
 
    References
 
    </p>
 
<br>
 
 
    <p style="font-size:0.6cm" align="justify">
 
 
<a name="tcu_references_1"></a>
 
<table width="100%" align="center" style="background-color: rgba(100%,100%,100%,0);line-height: 33px;">
 
<tr>
 
<td width="5%">[1]</td>
 
    <td width="90%">
 
Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles  in immune defense. Trends Immunol. 2009 Mar; 30(3):131-41. doi: 10.1016/j.it.2008.12.003. Epub 2009 Feb 13.
 
    </td>
 
    </tr>
 
  </table>
 
<br>
 
<a name="tcu_references_2"></a>
 
<table width="100%" align="center" style="background-color: rgba(100%,100%,100%,0);line-height: 33px;">
 
<tr>
 
<td width="5%">[2]</td>
 
    <td width="90%">
 
Huang HN, Rajanbabu V, Pan CY, Chan YL, Wu CJ, Chen JY. Use of the antimicrobial peptide Epinecidin-1 to protect against MRSA infection in mice with skin injuries. Biomaterials. 2013 Dec; 34(38):10319-27. doi: 10.1016/j.biomaterials.2013.09.037. Epub 2013 Sep 27.
 
 
</td>
 
    </tr>
 
  </table>
 
<br>
 
<a name="tcu_references_3"></a>
 
<table width="100%" align="center" style="background-color: rgba(100%,100%,100%,0);line-height: 33px;">
 
<tr>
 
<td width="5%">[3]</td>
 
    <td width="90%">
 
Maselli VM, Bilusich D, Bowie JH, Tyler MJ. Host-defence skin peptides of the Australian Streambank Froglet Crinia riparia: isolation and sequence determination by positive and negative ion electrospray mass spectrometry. Rapid Commun Mass Spectrom. 2006; 20(5):797-803.
 
</td>
 
    </tr>
 
  </table>
 
 
<br>
 
<a name="tcu_references_4"></a>
 
<table width="100%" align="center" style="background-color: rgba(100%,100%,100%,0);line-height: 33px;">
 
<tr>
 
<td width="5%">[4]</td>
 
    <td width="90%">
 
Tokuyasu K, Kaneko S, Hayashi K, Mori Y. Production of a recombinant chitin deacetylase in the culture medium of Escherichia coli cells. FEBS Lett. 1999 Sep 10; 458(1):23-6.
 
</td>
 
    </tr>
 
  </table>
 
<br>
 
 
<table width="100%" align="center" style="background-color: rgba(100%,100%,100%,0);line-height: 33px;">
 
<tr>
 
<td width="5%">[5]</td>
 
    <td width="90%">
 
Fujii T, Miyashita K. Multiple domain structure in a chitinase gene (chiC) of Streptomyces lividans. J Gen Microbiol. 1993 Apr; 139(4):677-86.
 
</td>
 
    </tr>
 
  </table>
 
<br>
 
    </p>
 
</font>
 
</span>
 
</td>
 
<td width="3%"></td>
 
  </tr>
 
</table>
 
</div>
 
<br><br><br><br><br>
 
</body> 
 
</html>
 
{{TCU_Taiwan/CSSfooter}}
 

Latest revision as of 05:33, 4 September 2015